Objectives: To analyze ambulatory prescribing practice and to assess the costeffectiveness of asthma pharmacotherapy in country settings. MethOds: It is a prospective prescribing practice and cost-effectiveness analysis. During 2008-2011 were observed 238 patients in Plovdiv region and collected information about their ambulatory asthma pharmacotherapy. Prescribed medicines were systematized in INN groups of mono and fixed dose combination products. The FEO1 and percentage of patients without exacerbation were used as measure of the therapeutic results. Incremental cost-effectiveness ratio was calculated and with Tornado diagram was explored the sensitivity of the results. Results: Pharmacotherapy with fixed dose combination was performed mainly with Beclomethazone/formoterol; Budesonide/ formoterol; and Salmeterol/fluticasone. The monthly cost of pharmacotherapy is varying among 35 and 50 Euro. Incremental cost effectiveness ratio is favoring the combination Beclomethazone/ formoterol 100/6 mcg with ICER of 324 Euro for additional increase in FEO1, and 50 Euro ICER for additional patient without exacerbation, although all alternatives are cost-effective because all ICERs fall below the GDP per capita. The monotherapy was performed with Beclomethazone, Fluticasone, Budesonide, Ciclesonide, and Montelukast. Its monthly cost was among 19 and 40 Euro. Incremental cost effectiveness ratio is favoring ciclesonide that is a dominant alternative as monotherapy for both studies outcomes. Results are sensitive to the changes in therapeutic outcomes. cOnclusiOns: The real life therapy follows the international guidelines but less fixed dose combinations were prescribed in comparison with international recommendations. Beclomethazone/ formoterol fixed dose combination and ciclesonide as monotherapy are cost-effective alternatives for the observed health care settings.
The aim of the study was to research the hyperbaric oxygenation effect on the condition of patients in the course of complex treatment aimed at rehabilitation after suffering from COVID-19 pneumonia. Results: the impact of hyperbaric oxygenation on the body of patients who have suffered from the novel coronavirus infection provides a positive dynamics and improves their quality of life. Conclusion: in the process of rehabilitating patients who have undergone the new coronavirus infection, it is necessary to use various physiotherapeutic measures, including hyperbaric oxygenation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.